Pharmaids Pharmaceuticals Declares Unaudited Financial Results

Pharmaids Pharmaceuticals Limited announced that its Board of Directors, in a meeting held on August 12, 2026, approved the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026. A Limited Review Report from statutory auditors M/s PPKG & Co. is enclosed. The company also approved the notice for its 37th Annual General Meeting (AGM), which will be conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). Further details and the complete financial results will be published in newspapers with a QR code linking to the company's webpage.